Larisa Yeomans

Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy

Kathleen A. Stringer, John G. Younger, Cora McHugh et al. · Shock · 2015 · 69 citations · Full text

Metabolomic Profiling, Metabolic Detail, Whole Blood +19

Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance

Henry I. Mosberg, Larisa Yeomans, Jessica P. Anand et al. · Journal of Medicinal Chemistry · 2014 · 55 citations · Full text

Pain Disorders, Pain Medicine, Molecular Pain +22

Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands

Henry I. Mosberg, Larisa Yeomans, Aubrie A. Harland et al. · Journal of Medicinal Chemistry · 2013 · 48 citations · Full text

Opioid Peptidomimetics, Tetrahydroquinoline Scaffold, Peptide Science +21

Glycosylation Improves the Central Effects of DAMGO

John J. Lowery, Larisa Yeomans, Charles M. Keyari et al. · Chemical Biology & Drug Design · 2007 · 44 citations · Full text

Glycopeptides Related to β-Endorphin Adopt Helical Amphipathic Conformations in the Presence of Lipid Bilayers

M. Dhanasekaran, Michael M. Palian, Isabel D. Alves et al. · Journal of the American Chemical Society · 2005 · 42 citations